This article is based on a poster originally authored by Maryam Ahmadi, Elena Shvets, Frank Gesellchen, Jitender Bisht, Joshua Stewart, Manju Namdeo, Marco Stefano Torrisi, Sophie Davies, and Richard ...
Antibody therapeutics are a dominating feature of the current drug development landscape, but increasing costs and time-consuming workflows represent major barriers to their discovery and development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results